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Epithelial cells contain noncentrosomalmicrotubules
(MTs), whose minus ends are oriented apically. In
contrast with the well-known interactions of the
minus ends with the centrosome, little is known
about the termination site of the noncentrosomal
minus ends. Here we show that a population of MT
minus ends is anchored at the zonula adherens
(ZA), the apical-most part of the cadherin-based
adherens junction, via a protein that we have termed
Nezha. We initially identified PLEKHA7 as a ZA com-
ponent and subsequently detected Nezha as a part-
ner for PLEKHA7. Nezha bound MTs at their minus
ends and tethered them to the ZA. Furthermore, we
found that a minus end-directed motor, KIFC3, was
concentrated at the ZA in a PLEKHA7/Nezha/MT-
dependent manner; and depletion of any of these
proteins resulted in disorganization of the ZA. We
propose that the PLEKHA7/Nezha/MT complex
regulates the ZA integrity by recruiting KIFC3 to this
junctional site.
INTRODUCTION
Microtubules (MTs) are a major component of the cytoskeleton,
and they play important roles in various cellular processes. In
many cell types, MTs are organized in a radial array with their
minus ends anchored at the centrosome and their plus ends
extending toward the cell periphery where they play a number
of biological roles (Akhmanova and Hoogenraad, 2005). On the
other hand, many types of terminally differentiated cells contain
a substantial number of noncentrosomal MTs, in addition to the
centrosomal ones (Bartolini and Gundersen, 2006). In polarized
epithelial cells, the former are arranged along the apicobasal
axis of the cell with their minus ends oriented apically and their
plus ends basally (Bacallao et al., 1989). Where these minus
ends terminate and what cellular processes are regulated by
the noncentrosomal minus ends are, however, largely unknown
(Dammermann et al., 2003).948 Cell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc.MTs are known to interact with the cell-cell adhesion machin-
ery. Cell junctions of epithelial cells comprise the tight junction,
adherens junction (AJ), and desmosome, which together form
the junctional complex at the apical end of the lateral cell-cell
contacts of these cells (Vogelmann and Nelson, 2005). The AJs
are organized by cadherins and associated cytoplasmic
proteins, including b-catenin and p120-catenin; and these AJs
form the ‘‘zonula adherens’’ (ZA) or ‘‘adhesion belt,’’ which
enclose the polarized epithelial cells at their near-apical end,
together with the underlying actin fibers. Recent studies showed
that MT plus ends terminated at the AJs of mammary tumor cells
and that MT depolymerization caused disorganized accumula-
tion of E-cadherin in these cells (Stehbens et al., 2006), as
observed earlier with other cells (Waterman-Storer et al., 2000),
suggesting that MTs are required for AJ assembly. In addition,
N-cadherin was found to be transported to the plasma mem-
brane, dependent on MT networks as well as MT-based motors
(Mary et al., 2002; Teng et al., 2005). The M-cadherin-catenin
complex was also shown to interact with MTs (Kaufmann
et al., 1999). Other studies showed that b-catenin bound dynein,
which may play a role in tethering MTs at the AJs (Ligon et al.,
2001) and that this tethering of MT plus ends at the AJs promoted
the delivery of connexin hemichannels to the cell-cell border
(Shaw et al., 2007). Although most of these studies suggest
that MT plus ends interact with cell junctions, another study
reported that N-cadherin-mediated adhesion stabilized the
minus ends (Chausovsky et al., 2000).
To further explore the functional and structural relationships
between the AJ and MTs, we paid particular attention to p120-
catenin (p120) because we and others earlier found that p120
had the ability to associate with MTs (Chen et al., 2003; Franz
and Ridley, 2004; Ichii and Takeichi, 2007; Yanagisawa et al.,
2004). For example, when p120-GFP was overexpressed in
cells, this construct became associated with MTs in an N-termi-
nal region-dependent manner (Ichii and Takeichi, 2007). These
observations raise the possibility that, in the natural setting,
p120 coupled with cadherin might also interact with MTs,
presumably with this interaction being mediated by other pro-
teins. To test this possibility, in this present study we searched
for proteins interacting with the p120 N-terminal region and
identified a novel molecule, PLEKHA7 (pleckstrin homology
domain-containing, family A member 7) (Gerhard et al., 2004;
Strausberg et al., 2002). We subsequently identified another
novel protein, which we designated as Nezha (a deity in Chinese
mythology), as a binding partner for PLEKHA7. These two pro-
teins were localized along the ZA but not at the other parts of
the AJ. Unexpectedly, we found Nezha to be associated with
the minus ends of MTs, supporting the idea that the cadherin-
p120 complex or AJ is linked with MTs, but via their minus
ends rather than via their plus ones.
The above form of MT-ZA association prompted us to hypoth-
esize that minus end-directed motors may utilize these MTs as
a track for reaching the ZA. In fact, we found that one of the
kinesin-14 family members, KIFC3, was concentrated in the ZA
and that its junctional localization was abolished by RNAi-medi-
ated depletion of PLEKHA7 or Nezha. Depletion of PLEKHA7,
Nezha, or KIFC3 also resulted in disorganization of the ZA.
Thus, we found a novel MT minus-end-anchoring mechanism,
as well as one of its functions, which was important to maintain
the integrity of the ZA.
RESULTS
Identification of PLEKHA7 as a p120-Catenin Partner
To search for proteins interacting with the N-terminal region of
p120-catenin (p120), we generated a GST fusion protein for
this domain (N-GST) or an N-terminus-deleted p120 (DN-GST;
Figure 1A) and incubated them with lysates of human colon car-
cinoma Caco2 cells. Mass spectrometric analysis of the mate-
rials pulled down with these fusion proteins showed that an
isoform of PLEKHA7 specifically cosedimented with the p120
N-terminal domain. PLEKHA7 is a protein that has WW, PH
(pleckstrin homology), and CC (coiled-coil) domains (Figure 1B),
but its biological function has not been characterized yet. To con-
firm the binding of PLEKHA7 with the p120 N-terminal domain,
we constructed a Flag-tagged PLEKHA7 (PLEKHA7-Flag) and
transfected Caco2 cells with this construct. The lysates of these
transfectants were then incubated with N-GST,DN-GST, or GST.
The results of this pull-down assay showed that PLEKHA7-Flag
was precipitated only with the N-GST (Figure 1C). Next, we
used a lysate of the above PLEKHA7-Flag or control transfec-
tants to examine whether this PLEKHA7-Flag could be coimmu-
noprecipitated with endogenous p120, and we found that
anti-Flag antibodies could cosediment p120 only from the
PLEKHA7-Flag transfectants (Figure 1D). The immunoprecipi-
tates from the PLEKHA7-Flag transfectants also contained
E-cadherin (Figure 1D), as well as a- and b-catenin (data not
shown), suggesting that PLEKHA7 was associated with the
E-cadherin-catenin complex via p120. Further analysis deter-
mined that a portion from aa 538 to 696 of PLEKHA7 was required
for its binding to p120 (Figure S1 available online).
Next, we generated antibodies against human PLEKHA7.
These antibodies recognized two bands with molecular masses
of 135 kDa and 145 kDa in western blots (Figure S2A), of which
the 135 kDa band was the dominant one. Immunofluorescence
staining of Caco2 cells showed that PLEKHA7 was localized
along cell-cell junctions (Figure 1E). In Caco2 cell-cell junctions,
an earlier study showed that there are two populations of
E-cadherin: one is linearly localized along the apical-most por-
tion of the junction, corresponding to the ZA, and the other isdistributed as a meshwork or puncta at the lower portions of
the junction (Otani et al., 2006). Double-immunostaining for
PLEKHA7 and E-cadherin revealed that PLEKHA7 was localized
only along the ZA (Figure 1E). A similar localization of PLEKHA7
was observed in other epithelial cell lines, as well as in embryonic
epithelial and neural tissues (data not shown). PLEKHA7 was
also detected in the centrosomes (Figure S2B).
To confirm whether the above PLEKHA7 distribution was me-
diated by p120, we examined the effect of p120 depletion. At the
junctions of p120 siRNA-treated Caco2 cells, PLEKHA7 was re-
duced in simple proportion to the reduction of p120 level
(Figure S3A). E-cadherin localization was also affected in these
cells, as expected from earlier observations (Reynolds, 2007).
However, E-cadherin level declined in a fashion less sensitive
to the p120 reduction than that of PLEKHA7 (Figure S3A), sug-
gesting that only the latter was proportional to the p120 level.
To further corroborate the involvement of p120, we used cad-
herin-deficient Neuro-2a cells (Ichii and Takeichi, 2007). These
cells were transfected with a normal cadherin, or its mutant
cN/JM(-), in which the p120-binding region had been deleted
(Aono et al., 1999). In the normal cadherin transfectants,
PLEKHA7 was recruited to the cell-cell contact sites, whereas
this did not occur in the mutant transfectants (Figure S3B). These
observations support the idea of the p120-dependent recruit-
ment of PLEKHA7 to the junctions.
PLEKHA7 Regulates Zonula Adherens Integrity
To explore the functions of PLEKHA7, we first exogenously ex-
pressed PLEKHA7-GFP in Caco2 cells and found that this con-
struct was also selectively localized along the ZA. Intriguingly,
the overexpressed PLEKHA7 molecules upregulated the level
of E-cadherin accumulating at the ZA while concomitantly down-
regulating its level at the lower portions of the junction
(Figure 1F). The junctional localization of p120 and other catenins
responded to the PLEKHA7 overexpression in a similar fashion
(data not shown), suggesting that excess PLEKHA7 redistributed
the E-cadherin-catenin complex to the ZA, removing it from the
lower portions of the cell junction.
Next, we knocked down the expression of PLEKHA7 in Caco2
cells by using siRNAsspecific for thismolecule. The overall level of
PLEKHA7 in the culture was significantly reduced by the siRNA
treatment (Figure S2C). After depletion of PLEKHA7, the intensity
of E-cadherin signals distributed along the ZA was strongly re-
duced; whereas the lower lateral components of E-cadherin
were not much affected (Figure 1G). p120 and a- and b-catenin
were also eliminated from the ZA (data not shown). The circumfer-
ential actin belts remained intact along the ZA after PLEKHA7 de-
pletion, although disassembled actin fibers were more frequently
observed (Figure S2D); and the accumulation of ZO-1and desmo-
plakin, markers for tight junction and desmosome, respectively,
was not particularly altered by PLEKHA7 depletion (Figure S2E).
These observations suggest that PLEKHA7 was specifically im-
portant for the cadherin-catenin accumulation at the ZA.
PLEKHA7 Binds Nezha, a Novel Protein Localizing
at the Zonula Adherens
In order to investigate the mechanisms for the PLEKHA7-de-
pendent regulation of cadherin assembly, we conductedCell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc. 949
Figure 1. PLEKHA7 Associates with p120 and Localizes at the Zonula Adherens
(A) Structural views of mouse p120 and its fusion constructs with GST. ARM, armadillo domain.
(B) Structural view of human PLEKHA7.
(C) In vitro interactions of the p120 N-terminal domain with PLEKHA7. GST-fusion proteins (left, asterisks) were incubated with a lysate of Caco2 cells transiently
transfected with PLEKHA7-Flag and then pulled down with Glutathione-Sepharose 4B beads. Coprecipitated materials were detected with anti-Flag antibodies
(right).
(D) PLEKHA7 associates with p120 and E-cadherin. Caco2 cells were transiently transfected with PLEKHA7-Flag or control vector, and then their lysates (left)
were subjected to immunoprecipitation with anti-Flag antibodies. In the immunoprecipitates, p120 and E-cadherin were detected by immunoblotting (right).950 Cell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc.
pulldown assays using PLEKHA7-GST fusion proteins to
screen for proteins that interact with PLEKHA7. One construct
comprising GST and a PLEKHA7 fragment (from aa 680 to 821)
corresponding to its CC domain (Figure S4A) interacted with
an as yet uncharacterized 150 kDa protein (KIAA1543), and
we termed this protein Nezha. Nezha comprises one calponin
homology (CH) and two coiled-coil (CC1 and 2) domains, as
well as one DUF1781 (DUF) domain of unknown function
(Figure 2A). We generated antibodies against Nezha. Western
blot analysis of Caco2 cell lysates with these antibodies de-
tected two bands, a major one with a molecular mass of
150 kDa and a minor one of 160 kDa (Figure 2A); and these
bands became undetectable after RNAi-mediated depletion
of Nezha, assuring the specificity of the antibodies (see
Figure 2E). Next, we examined, by using a lysate of Caco2 cells
doubly transfected with PLEKHA7-Flag and EGFP-tagged Nezha
(Nezha-GFP) or control EGFP, whether Nezha could be coimmu-
noprecipitated with PLEKHA7 and found that anti-GFP antibodies
precipitated PLEKHA7-Flag only from the Nezha-GFP transfec-
tants (Figure 2B). We further found that anti-Nezha antibodies
not only precipitated endogenous Nezha itself but also coprecipi-
tated endogenous PLEKHA7 (Figure 2C). Deletion analysis of
Nezha showed that the C-terminal region from aa 943 to 1225 con-
tained the site required for its association with PLEKHA7
(Figure S4B).
In immunofluorescence staining of Caco2 cells, Nezha was
detected as punctate signals scattered in the cytoplasm, but
this protein was also localized along the ZA together with
PLEKHA7 (Figure 2D). This junctional localization of Nezha
became detectable only at mature cell-cell contacts, e.g., at 3
days under the present culture conditions (see Experimental
Procedures), whereas PLEKHA7 appeared by 1 day. To examine
whether the distribution of Nezha could be regulated by
PLEKHA7, we depleted PLEKHA7 by treating Caco2 cells with
specific siRNAs and found that the Nezha signals disappeared
from the cell junctions, but not from the cytoplasm (Figure 2D),
suggesting that the junctional localization of Nezha, but not the
cytoplasmic one, was dependent on PLEKHA7. Reciprocally,
when Nezha had been depleted by siRNAs specific for this pro-
tein, the PLEKHA7 distribution pattern became irregular; and the
ZA-associated E-cadherin became reduced and discontinuous
(Figures 2E and 2F). These observations suggest that Nezha,
once associated with PLEKHA7, serves to maintain the integrity
of the ZA. As found for PLEKHA7, Nezha depletion did not affect
ZO-1 accumulation (see Figure S11).Nezha Binds with MTs at the Minus Ends
To explore the biological functions of Nezha, we constructed a se-
ries of Nezha deletion mutants tagged with EGFP and transfected
Caco2 cells with their cDNAs (Figure S5A). Immunostaining for
EGFPanda-tubulinsuggested that overexpressedNezha wasas-
sociated with MTs, inducing their bundling, and that this MT-bun-
dling ability of Nezha required the C-terminal region (Figure S5A),
which also contained the PLEKHA7-binding site, as mentioned al-
ready (Figure S4). For biochemical confirmation of the Nezha-MT
interaction, we prepared an extract of Caco2 cells and added car-
rier tubulins and then Taxol (pacilitaxel) to the solution, according
to a method previously described (Vallee, 1982). The MT pellets
collected from this extract contained Nezha (Figure S5B). When
a recombinant Nezha-Flag was mixed with purified tubulins, these
proteins also coprecipitated (Figure S5C), strongly suggesting
that Nezha could directly bind MTs.
These observations prompted us to analyze the cytological re-
lationship between endogenous Nezha and MTs. We double-im-
munostained for these two molecules in Caco2 cells and found
that the Nezha signals were mostly localized at one end of non-
centrosomal MTs (Figure 3A). To characterize this localization,
we triple-immunostained for MTs, Nezha, and EB1, a protein
known to bind exclusively to the MT plus end (Mimori-Kiyosue
et al., 2000; Su et al., 1995). Strikingly, Nezha and EB1 were dis-
tributed differently (Figure 3B), and high-magnification images
showed that these two proteins were localized at the opposite
ends of noncentrosomal MTs (Figure 3C). These results suggest
that Nezha bound to the minus end of noncentrosomal MTs. On
the other hand, Nezha was not detected at the centrosomes
marked by g-tubulin staining (Figures S6A and S6B), except
that overexpressed Nezha recruited g-tubulin onto Nezha-
induced MT bundles (Figure S6C). It is known that ninein, a
centrosomal minus-end capping protein, is released from the
centrosomes and redistributed to the apical cortex of cells (Mo-
gensen et al., 2000) or desmosomes (Lechler and Fuchs, 2007)
and that these ninein molecules anchor MTs at these respective
sites, like Nezha. However, double-immunostaining for ninein
and Nezha showed that their distributions did not overlap
(Figure S7). Desmoplakin depletion also did not affect the junc-
tional localization of Nezha (data not shown).
To further characterize the minus-end-specific binding nature
of Nezha, we performed an in vitro MT-capping experiment (Wi-
ese and Zheng, 2000). For this assay, we chose a C-terminal-half
fragment of Nezha (Nezha-CC1F), whose MT-bundling ability
was cytochemically indistinguishable from that of the full-length(E) Double-immunostaining for endogenous PLEKHA7 and E-cadherin in Caco2 cells. The boxed area is enlarged in the rightmost panel. Nuclear signals seen in
this and other panels are thought to be nonspecific ones unique to our rabbit anti-PLEKHA7 pAbs, as these signals were unchanged after PLEKHA7 depletion.
(F) PLEKHA7 overexpression enhances E-cadherin distribution at the ZA. Exogenous PLEKHA7-GFP, introduced into Caco2 cells, and E-cadherin were double-
immunostained in a mixed culture of GFP-positive and -negative cells. The two boxed areas are enlarged at the right, where exogenous PLEKHA7 is expressed in
‘‘a’’ but not in ‘‘b.’’ Arrowheads indicate the ZA. Relative fluorescence intensity of E-cadherin signals distributed from the basal-most to apical-most portions was
measured, choosing tilted junctions, and the fluorescence was scanned along the apicobasal lines (n = 5) drawn at random positions, one of which is shown in
cyan as an example. The fluorescence value at the ZA was compared in the presence and absence (control) of exogenous PLEKHA7. *p < 0.01, n = 3 independent
experiments (50 cells/n). Error bars represent the standard deviation (SD). The E-cadherin level was quantified in this way also in other figures.
(G) PLEKHA7 depletion downregulates E-cadherin accumulation at the ZA. Caco2 cells were transiently transfected with control or PLEKHA7 siRNA, and
PLEKHA7 and E-cadherin were then double-immunostained. In the ZA of PLEKHA7-depleted cells (asterisks), E-cadherin signals are reduced (arrows).
*p < 0.01, n = 3 independent experiments (50 cells/n). Error bars represent the SD.
Scale bars: 10 mm.Cell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc. 951
Figure 2. Nezha Interacts with PLEKHA7 and Regulates E-Cadherin Assembly
(A) Immunoblot detection of Nezha in Caco2 cells, and a structural view of human Nezha.
(B) Interaction of PLEKHA7 and Nezha. Caco2 cells were transiently transfected with PLEKHA7-Flag and Nezha-GFP or control GFP vector (left), and their lysates
were subjected to immunoprecipitation with anti-GFP antibodies. The immunoprecipitates were then analyzed with anti-GFP and anti-Flag antibodies (right).
(C) Coimmunoprecipitation of endogenous Nezha and PLEKHA7 with anti-Nezha antibodies obtained from a Caco2 cell lysate.
(D) Endogenous Nezha and PLEKHA7 are colocalized at the ZA, and the junctional distribution of Nezha is PLEKHA7 dependent. Caco2 cells were transfected
with control or PLEKHA7 siRNA and then double-immunostained for PLEKHA7 and Nezha. Only the junctional Nezha signals disappear after PLEKHA7 depletion.
(E and F) Nezha depletion perturbs E-cadherin (E) and PLEKHA7 (F) localization. Caco2 cells were transfected with control or Nezha siRNA and subsequently
double-immunostained for Nezha and E-cadherin or PLEKHA7. Asterisks mark Nezha-depleted cells. The siRNA-dependent Nezha depletion was confirmed
by immunoblotting. The E-cadherin level at the ZA was quantified. *p < 0.01, n = 3 independent experiments (50 cells/n). Error bars represent the SD. The boxed
areas are enlarged at the right.
Scale bars: 5 mm.952 Cell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc.
Figure 3. Nezha Localizes at Noncentrosomal MT Minus Ends
(A) Nezha localizes at one end of MTs. Caco2 cells were double-immunostained for Nezha and a-tubulin. The lower photo is an enlargement of part of the upper
one.
(B) Nezha and EB1 are differentially localized. Caco2 cells were triple-immunostained for Nezha, a-tubulin, and EB1.
(C) Higher-magnification image of a cell stained as in (B). Each set of arrow and arrowhead points to Nezha and EB1 signals, respectively, localized on the op-
posite ends of a noncentrosomal MT.
(D) In vitro MT capping experiments. Structural views of Nezha and its His-tagged fragment used for this study are shown. MTs were sequentially polymerized with
rhodamine-labeled tubulins and nonlabeled ones in the presence of Alexa 488-labeled His-Nezha-CC1F or mouse IgGs. Nezha-CC1F (green) marks the brighter
seed ends, as indicated by the arrowheads. Approximately 35% of MTs were associated with Nezha, and out of them, 67% were attached to Nezha at the brighter
end, with the others attached to unspecified positions.
Scale bars: 5 mm (A and B) and 1 mm (C and D).Nezha (Figure S5A), and constructed an Alexa 488-labeled,
His-tagged Nezha-CC1F recombinant protein (Figure 3D). To
a solution of this protein, rhodamine-labeled and unlabeled tubu-
lins were sequentially added. This protocol led to the production
of chimeric MTs with high and low rhodamine intensities, in
which the portion with brighter rhodamine signals corresponded
to the minus-end side (Wiese and Zheng, 2000). We found that
Nezha-CC1F was consistently localized at the brighter end of
the chimeric MTs (Figure 3D). Thus, we could biochemically con-
firm that Nezha bound the MT minus end.
Dynamics of MTs Anchored at Nezha
To observe Nezha and associated MTs in living cells, we doubly
transfected Caco2 cells with kusabira orange-labeled Nezha
(Nezha-KOR) and GFP-a-tubulin and recorded their behavior
by time-lapse movies, choosing thin peripheries of cells, whichallowed us to obtain high-resolution imaging. These movies
showed intriguing dynamics of these molecules: Individual Nezha
puncta were located at an almost fixed position, and from each
punctum, a single MT emerged, which showed repeated exten-
sion and retraction (Figure 4A and Movie S1). These results sug-
gest that Nezha provided an anchoring point for the minus ends of
MTs, allowing their dynamic elongation and shortening.
We also observed the dynamics of MT plus ends in relation to
Nezha by doubly introducing EB1- or EB3-GFP and Nezha-KOR
into Caco2 cells. The movie showed that a novel EB1 signal ap-
peared directly from a Nezha-positive site and moved away,
and this process was repeated (Figure 4B and Movie S2). These
results confirmed that Nezha or Nezha-bearing structures sus-
tained the repetitive plus-end growth of MTs. In this imaging,
on the other hand, we did not distinguish whether the observed
Nezha signals were derived from the ones localized in the cellCell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc. 953
Figure 4. Dynamics of MTs Anchored at Nezha
(A) Time-lapse recording of Nezha-kusabira orange (KOR) and a-tubulin-GFP expressed in a Caco2 cell (see also Movie S1). Montage images (upper right) and
kymograph (lower right) of the Nezha-MT complex indicated by the arrowhead are shown. Broken line shows the dynamics of the plus end.
(B) Time-lapse recording of Nezha-KOR and EB1-GFP expressed in a Caco2 cell. Upper left, reconstruction image of Movie S2. Yellow broken arrows indicate
three independent tracks of growing EB1. Upper right and lower, the boxed region is shown by montage images, as well as by kymograph sampled at the cyan
line. White arrows indicate the growing and regrowing MT plus ends, and arrowheads point to a Nezha-positive structure.
(C) Nezha-MT complexes localize on PLEKHA7 signals at cell junctions. Caco2 cells were triple-immunostained for Nezha, a-tubulin, and PLEKHA7. The boxed
region was enlarged below.
(D) Time-lapse recording of a junctional Nezha-MT complex. Nezha-GFP and EB3-RFP were doubly expressed in a Caco2 cell, and images were acquired at 2 s
intervals. Montage images of the region boxed in the right panel are shown. Arrowheads indicate a fixed Nezha signal, and arrows point to EB3 signals growing
out of the Nezha signal. Dark arrowheads and the dotted line indicate the boundary of the transfected cell and nontransfected cell in contact with each other.
Scale bars: 2 mm.junctions or not. To analyze the interactions between Nezha and
MTs at cell junctions, we triple-immunostained for Nezha, PLE-
KHA7, and MTs and found that the Nezha-MT complexes were
localized in the PLEKHA7-positive zones (Figure 4C), supporting954 Cell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc.the model that these complexes were associated with PLEKHA7.
We also purposely chose Nezha signals located at cell-cell
boundaries for time-lapse recording and found a similar move-
ment of EB1 or EB3 away from these Nezha puncta (Figure 4D).
KIFC3 Is Recruited to the Zonula Adherens
in a PLEKHA7/Nezha-Dependent Manner
It was previously shown that dynein, a minus end-directed mo-
tor, was localized in cell junctions (Ligon et al., 2001). This led
us to consider the possibility that a function of the MTs tethered
to the PLEKHA7-Nezha complex at the minus end is to provide
a track for dynein or other minus end-directed motors to reach
the AJs. We therefore tested this possibility and actually found
that KIFC3 (Yang et al., 1997), a minus end-directed motor,
was localized along the ZA of Caco2 cells (Figure 5A), as well
as in the centrosomes (Figure S8A). This junctional localization
of KIFC3 was evident only at mature cell junctions, as in the
case of Nezha. When PLEKHA7 or Nezha had been deleted,
KIFC3 was diminished at cell junctions but not at the centro-
somes (Figure 5B). In addition, overexpressed PLEKHA7 en-
hanced the recruitment of KIFC3 to the ZA in early cultures,
where its accumulation to cell junctions was still incomplete; like-
wise, overexpression of Nezha, which induced MT bundling, re-
cruited KIFC3 to the Nezha-positive sites (Figure S8B). All these
observations suggest that KIFC3 was transported to cell junc-
tions in a manner dependent on the PLEKHA7-Nezha complex.
Next, we attempted to visualize the KIFC3 recruitment to cell
junctions by live-cell imaging: We doubly transfected Caco2 cells
with EGFP-tagged KIFC3 (KIFC3-GFP) and kusabira orange-
tagged E-cadherin (Ecad-KOR) and observed their behavior by
time-lapse recording. The movies showed that, although exoge-
nous KIFC3 tended to form static aggregates, there was a popu-
lation of small KIFC3 clusters that actively moved from the cyto-
plasmic zones to the E-cadherin-positive junction and then
settled there (Figure 5C and Movie S3). When the KIFC3 clusters
below 0.27 mm in diameter were chosen for measurement, 36%
of them showed such movement with a speed of 216 ± 81.9 nm/s
(mean ± standard deviation [SD], n = 20). Such translocation of
cytoplasmic KIFC3 to the cell junction was, however, not ob-
served in nocodazole-treated transfectants (see below). We
also observed that KIFC3 signals were associated with MTs ori-
ented toward cell junctions in fixed samples (Figure 5D).
To examine the function of KIFC3, we knocked down its ex-
pression in Caco2 cells by using KIFC3-specific siRNA. After
the KIFC3 depletion, E-cadherin signals at the ZA were disorga-
nized (Figure 5E), as observed in PLEKHA7- or Nezha-depleted
cells, suggesting that PLEKHA7, Nezha, and KIFC3 work to-
gether for the regulation of cadherin assembly at the ZA.
Microtubules Are Essential in the Actions
of the Nezha-KIFC3 System
We examined how MTs themselves were involved in the above
systems. We treated Caco2 cells with 10 to 20 mM nocodazole
for 30 min to 6 hr and observed the junctional distributions of
the proteins studied above. MT depolymerization began within
30 min, progressively affecting the distribution of Nezha,
KIFC3, and PLEKHA7/E-cadherin in this sequence: Nezha
signals disappeared from cell-cell boundaries by 30 min
(Figure S9A), indicating that the junctional localization of Nezha
depended on its binding to MTs. KIFC3 signals began to be dis-
organized at 1 hr and disappeared by 2 hr from the junctions
(Figure S9B); concomitantly, their movement toward the junction
ceased, as mentioned above. During these incubation times, thelocalization of PLEKHA7 and E-cadherin appeared to be un-
changed. At 6 hr, however, PLEKHA7 signals became zigzag
or fragmented, and E-cadherin delineating the ZA became re-
duced and discontinuous (Figures S9C and S9D). These results
confirmed the specific requirement of MTs for the ZA assembly
but simultaneously indicated that the sensitivity of these proteins
to MT depolymerization differed. The delayed response of
E-cadherin could be explained by its half-life in epithelial junc-
tions, which was estimated to be about 6 hr (Troxell et al., 1999);
that is, only the E-cadherin molecules newly redistributing to the
junctions might have been affected by the nocodazole treatment.
The above studies suggest that KIFC3 utilized the Nezha-
anchored MTs for accessing the junctions. If this is the case,
KIFC3 would be expected to behave differently from other junc-
tional proteins during their relocation to the junctions. We tested
this possibility by FRAP (fluorescence recovery after photo-
bleaching). The results revealed that the behavior of KIFC3
was unique, displaying a higher repopulation rate compared
with those of p120, PLEKHA7, and E-cadherin (Figure S10). Fur-
thermore, during the image capturing, we frequently observed
that KIFC3 puncta moved directly into the photobleached zones
of the junction from the cytoplasm. These observations support
the hypothesis that KIFC3 was distributed to the junction via
a specific route, likely MTs.
Finally, we compared the morphology of Caco2 cells after
depletion of these proteins by immunostaining for ZO-1, which
delineates the apical outline of epithelial cells. In all these cells,
the apical surface area was significantly expanded (Figure S11)
with concomitant flattening of the cells, suggesting that the
PLEKHA7-Nezha-KIFC3-dependent system is critical for cells
to maintain proper tension.
DISCUSSION
The mechanisms governing which subcellular structures or mol-
ecules regulate the dynamics of noncentrosomal MTs in epithe-
lial cells have not been well understood. In the present study, we
identified a novel protein, Nezha, that can anchor the MT minus
ends to noncentrosomal structures and therefore explored its
biological functions.
Nezha as a Regulator of MT Dynamics
The present studies have provided evidence that Nezha binds
noncentrosomal MTs via their minus ends. It is thought that non-
centrosomal MTs are generated by release from the centro-
somes or become nucleated from some noncentrosomal sites
(Bartolini and Gundersen, 2006; Mogensen and Tucker, 1987;
Vorobjev et al., 1997; Yvon and Wadsworth, 1997). In our live im-
aging of cells cotransfected with EB1 and Nezha, EB1 signals
appeared to emerge de novo from the sites where Nezha was
localized. These images suggest that Nezha may function as
an MT-nucleation center, rather than for simple anchoring of
pre-existing MTs. Whether Nezha has indeed a nucleation activ-
ity, however, remains to be further investigated. It is also unde-
termined whether Nezha organizes a subcellular structure
together with other proteins. Ninein is known to capture MTs at
their minus ends, like Nezha, suggesting their possible coopera-
tion. In our immunostaining experiments, however, Nezha didCell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc. 955
Figure 5. KIFC3 Is Recruited to the Zonula Adherens
(A) KIFC3 localizes along the ZA. Caco2 cells were doubly immunostained for KIFC3 and E-cadherin.
(B) The junctional distribution of KIFC3 depends on PLEKHA7 and Nezha. Caco2 cells were transfected with control, PLEKHA7, or Nezha siRNA. KIFC3 became
undetectable at cell junctions after PLEKHA7 or Nezha depletion but was still detectable at the centrosomes (arrow).
(C) Time-lapse recording of KIFC3-GFP and E-cadherin-KOR expressed in a Caco2 cell. Left, montage images of Movie S3. Arrowheads indicate KIFC3-GFP
signals moving toward the E-cadherin-positive junction. Upper right, kymograph for the KIFC3-GFP signals sampled at the cyan line indicated in the 0 s montage
image. Lower right, reconstruction image of the movie, in which the broken arrow indicates the track of moving KIFC3 signals. Broken lines indicate the ZA.
(D) Triple-immunostaining for endogenous KIFC3, MTs, and E-cadherin. Arrowheads indicate KIFC3 signals localized on a MT, which is associated with an
E-cadherin-positive site.
(E) KIFC3 depletion disorganizes E-cadherin assembly. Caco2 cells were transfected with control or KIFC3 siRNA. As indicated by the arrowheads, E-cadherin
signals were disorganized in the junctions formed between KIFC3-knocked down cells (marked with asterisks). The amount of E-cadherin at the ZA was quan-
tified. *p < 0.01, n = 3 independent experiments (50 cells/n). Error bars represent the SD.
Scale bars: 10 mm (A, B, and E) and 1 mm (C and D).not colocalize with ninein, suggesting that Nezha plays a unique
role, distinct from that of ninein.
We found two pools of Nezha, junctional and cytoplasmic. The
junctional Nezha was recruited to this site via its interaction with956 Cell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc.PLEKHA7. With regard to the cytoplasmic Nezha,we did not identify
the mechanismas tohow itwas localized in thecytoplasm.Although
Nezhamayhaveasimilar function in the junctionalandnonjunctional
sites, the present study was focused on the junction-located Nezha.
Nezha as a Component of the Adherens Junction
We first identified PLEKHA7 as a protein that interacted with
p120 and then Nezha as a PLEKHA7-binding partner. Since
PLEKHA7 was coimmunoprecipitated not only with p120 and
Nezha but also with E-cadherin, we can imagine the presence
of a molecular complex linked in the sequence of E-cadherin-
p120-PLEKHA7-Nezha, although the possibility that the
PLEKHA7-Nezha complex was present in the junctions indepen-
dently of the E-cadhein-p120-PLEKHA7 complex could not be
excluded. The association of Nezha with the junctions was MT
dependent. This finding suggests that a cooperative interaction
between Nezha and MTs regulates the binding of Nezha to
PLEKHA7. Both PLEKHA7 and MTs bound the C-terminal region
of Nezha, suggesting that their interactions with Nezha occur at
a nearby location; and this observation can be taken as a clue for
our future analysis of the cooperativity. Another important obser-
vation was that PLEKHA7 and Nezha were strictly localized
along the ZA, despite the fact that p120 was distributed through-
out cell-cell contacts, as were E-cadherin and other catenins.
There must be a mechanism to confer a specific property on
the cadherin-catenin complex to allow it to associate with these
proteins only at the ZA. In addition, it should be noted that p120
(Chartier et al., 2007; Franz and Ridley, 2004; Ichii and Takeichi,
2007) and PLEKHA7, as well as KIFC3, were capable of local-
izing in the centrosomes, suggesting a potential role of these
proteins in the centrosomes.
The role of p120 in cadherin-based junction formation has
been extensively studied, and one of its major functions is to sta-
bilize cadherin turnover in the cell membrane (Reynolds, 2007).
Whereas this role of p120 depends on the centrally located ar-
madillo domain (Liu et al., 2007), the site required for the interac-
tion of p120 with PLEKHA7 resides in the N-terminal domain.
Thus, our present study has identified a novel p120-dependent
mechanism for regulation of cell-cell contacts.
Nezha Cooperates with KIFC3 for the Maintenance
of the Zonula Adherens
Consistent with the localization of PLEKHA7 and Nezha, their de-
pletion selectively affected the E-cadherin-catenin complex lo-
calized at the ZA, but not its entire populations present at the
cell-cell contacts, highlighting that the PLEKHA7-Nezha system
is solely important for the integrity of the ZA. Then, how are the
Nezha-anchored MTs involved in this process? We found that
KIFC3 was localized along the ZA and demonstrated that
KIFC3 was moving to the junctions from the cytoplasm. This
movement was most likely MT dependent because it was
blocked with nocodazole, although it remained unclear whether
KIFC3 ‘‘migrated’’ on MTs in the same way as other kinesin mo-
tors do or interacted with MTs in some distinct manner. FRAP
analysis also indicated that KIFC3 was redistributed to the junc-
tions via a unique route. Importantly, KIFC3 depletion affected
cell junctions as did Nezha or PLEKHA7 depletion. This fact sug-
gests that KIFC3 is part of the PLEKHA7-Nezha-MT machinery.
Supporting this idea, MT depolymerization itself affected the
junction integrity in a pattern similar to that observed after the de-
pletion of PLEKHA7, Nezha, and KIFC3.
The detailed role of KIFC3, on the other hand, remains to be
explored. According to a previous report (Noda et al., 2001),KIFC3 is associated with apically transported vesicles. Such
vesicles may contain molecules necessary for the maintenance
of the ZA. We have never observed E-cadherin signals moving
together with KIFC3 in the cytoplasm, and therefore something
else might be transported by this motor protein. It is noteworthy
that the cell surface population of E-cadherin was not reduced
by depletion of PLEKHA7, Nezha, or KIFC3 (W.M., unpublished
data), suggesting that the system disclosed here is likely not im-
portant for the trafficking of cadherin molecules. On the other
hand, we cannot exclude the possibility that KIFC3 functions
as a regulatory or structural element of the adhesion protein
complex rather than as a cargo motor.
The Roles of Microtubules in the Cadherin-Based
Junctions
The involvement of MTs in AJ organization has already been re-
ported. For example, nocodazole treatment perturbs the ability
of cells to accumulate E-cadherin at cell-cell contacts in mam-
mary tumor cell lines (Stehbens et al., 2006), results that are at
least in part consistent with ours. However, in such studies, the
potential interactions of MT plus ends with cell junctions were
the matter of focus, and importantly, p120 was found not to be
required for these interactions. Thus, these and our results sug-
gest that p120 contributes to only the minus end-dependent in-
teractions of MTs with AJs. It is possible that both the MT minus
and plus ends play roles in AJ assembly, but likely in different
ways. Another report demonstrated that MT minus ends are sta-
bilized by the presence of cadherin-mediated junctions (Chau-
sovsky et al., 2000). This phenomenon might be explained by
assuming that the junction-associated Nezha plays a role in
the stabilization of the minus ends.
It should be stressed that Nezha and KIFC3 were recruited to
cell junctions only in the mature cell-cell contacts. The MT-
dependent system disclosed in this study is therefore likely im-
portant for the maintenance or modulation of mature AJs rather
than for the initiation of their formation. When these proteins
were removed, the apical area of Caco2 cells was expanded,
suggesting that the cells lost tension to maintain their morphol-
ogy. It is intriguing to study how such cell biological effects affect
tissue morphogenesis in vivo. Our preliminary observations of
the tissue distribution of Nezha in mouse embryos indicate that
this protein is expressed by various cell types including neuronal
cells, implying that it may have diverse functions. It should also
be re-emphasized that Nezha was distributed not only in the
junctions but also in other sites in the cells, and therefore this
protein likely plays a role at those sites, too, for MT minus-end
regulation. Further analysis of Nezha and associated proteins
may contribute to our deeper understanding of the dynamics
and roles of MT minus ends that are not anchored to the
centrosomes.
EXPERIMENTAL PROCEDURES
Plasmids
cDNA clones of human PLEKHA7 and mouse Nezha were obtained from the
Mammalian Gene Collection. For preparation of tagged constructs, PLEKHA7
was cloned into pEGFP (Clontech) or pCMVtag 2B (Stratagene) by PCR with
a DNA fragment set of 50-ATAAAGCTTAACATGGCGGCGGCGACGGTC-30
and 30-ATACTCGAGACATACTGAGCCAAGATCTCC-50; and Nezha wasCell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc. 957
cloned into pEGFP or pmKO1-MC1(MBL) by PCR with that of ATAAGATC
TATGGTGGAAGCGGCGCCC’-30 and 30-ATAGTCGACTTTGGGGGTACCGC
CACC-50. Their fragments were subcloned into the pEGFP vector with
a GFP-tag sequence on its 50 end or into the PQE30 vector (QIAGEN) with
a His tag sequence on its 30 end. A cDNA clone of human KIFC3 was kindly
provided by N. Hirokawa (University of Tokyo), and it was subcloned into
pEGFPC1. N-cadherin and its mutant, cN/JM(-) (Aono et al., 1999), were subcl-
oned into the pCA vector. Mouse p120 N-terminal (aa 1–346) and C-terminal
(aa 347–921) fragments were subcloned into PGEX-6P-1(GE Healthcare).
EB1-GFP and EB3-RFP were kindly given to us by Y. Mimori-Kiyosue (KAN In-
stitute). Human a-tubulin-pCAsalGFP and mouse E-cadherin pmKO1-MC1,
constructed by Y. Kametani, were used for imaging assays. The following siRNAs
were used: siPLEKHA7-1, 50-CCACGCUGUCAAGAACUCAUCUCAU-30;
siPLEKHA7-2, 50-GAGAGCGACACUGACGUCAAACUGA-30; siNezha-1, 50-
CAGCAGCCACCAACUCCGAGGUGAA-30; siNezha-2, 50-CAGAACGCAAGA
AACAGCUGGUGAA-30; sip120-1, 50-GGCUAGAGGAUGACCAGCGUAGUAU -30;
and sip120-2, 50- GCAGCUCCCAAUGUUGCCAACAAUA-30 (Stealth siRNAs,
Invitrogen); siKIFC3-1, 50-GUUUGAGUUUGGCCACACUUU-30; and siKIFC3-
2, 50- GAAACAUGUUCAGAAGGAAUU-30 (MISSION siRNAs, SIGMA). Nega-
tive-control stealth siRNAs were also obtained for the respective siRNAs
from Invitrogen or SIGMA.
Antibodies
Mouse monoclonal antibodies (mAbs) against a C-terminal portion (aa 721–
1121) of human PLEKHA7 or an N-terminal portion (aa 18–206) of mouse
Nezha were generated. Rabbit or rat polyclonal antibodies (pAbs) against
a C-terminal sequence (CPASYGPGEQNGTGGY) of human PLEKHA7 and
a C-terminal sequence (SRLPGSRERDWENG) of mouse Nezha were also gen-
erated and affinity-purified with antigen-coupled CH-Sepharose beads (GE
Healthcare), as described previously (Otani et al., 2006). The following anti-
bodies were also used: mouse mAb HECD-1 against human E-cadherin (Shi-
moyama et al., 1989); rat mAb ECCD2 against mouse E-cadherin (Shirayoshi
et al., 1986); mouse mAbs against p120-catenin and EB1 (BD Biosciences);
mouse mAb (Roche) and rabbit pAb (Chemicon) against GFP; mouse mAb
and rabbit pAb against ZO-1 (Zymed); mouse mAb (DM1A, Sigma-Aldrich),
rat mAb (YL1/2, Chemicon), and rabbit pAb (Cell Signaling) against a-tubulin;
mouse mAb against desmoplakin 1 and 2 (Progene); and rabbit pAb against
ninein (BIOLEGEND). The following secondary antibodies were used: goat
Alexa Fluor 488/594-conjugated anti-mouse or anti-rabbit IgG (Invitrogen);
sheep HRP-conjugated anti-mouse or anti-rabbit IgG (GE Healthcare); Alexa
Fluor 488-, 555-, 594-, or 647-conjugated secondary antibody (Molecular
Probes); Cy3-conjugated anti-rat IgG (Chemicon); peroxidase-conjugated
anti-rat IgG (Jackson); and peroxidase-conjugated anti-mouse or anti-rabbit
IgG (GE Healthcare).
Cell Culture and Transfection
Cells were cultured at an initial density of 5 3 104/cm2 in collagen-coated
dishes, with a 1:1 mixture of DME and Ham’s F12 supplemented with 10%
FCS. Cells at approximately 70% confluence were transfected by use of
FuGENE HD (Roche). For isolating stable transfectants, cells were exposed
to 400 mg/ml G418. For siRNA treatments, cells were transfected by using Lip-
ofectamine 2000 (Invitrogen). We generally obtained more than 90% reduction
in the protein level for the siRNAs used at 4 to 6 days after transfection, unless
otherwise noted, and we examined the effects of RNA interference at 5 days.
Immunofluorescence Staining
Cells were fixed and immunostained as described earlier (Otani et al., 2006).
Preparations were analyzed by using a laser-scanning confocal microscope
(LSM 510 mounted on an Axiovert 100M microscope, Carl Zeiss MicroImag-
ing) on an inverted stand with C-Apochromat 403/1.20 and Plan-Apochromat
633/1.40 objectives (Carl Zeiss MicroImaging).
Biochemical Assays
For immunoprecipitation, cells were lysed in a lysis buffer (50 mM Tris-HCl, pH
7.5, containing 50 mM NaCl, 0.5 mM EDTA, 0.5 mM EGTA, 1.5 mM MgCl2,
1 mM DTT, and 0.5% Triton X-100). Lysates, precleared with protein
G-Sepharose 4FF beads (GE Healthcare), were incubated with anti-Flag958 Cell 135, 948–959, November 28, 2008 ª2008 Elsevier Inc.mAb antibody or anti-Nezha pAb for 1 hr, followed by incubation with protein
G-Sepharose beads for 1 hr. The beads were subsequently washed three
times in the lysis buffer. For pulldown assays, cells were lysed in the HS-buffer
(20 mM Tris-HCl, pH 7.4, containing 500 mM NaCl, 5 mM MgCl2, and 1% Triton
X-100). GST proteins (10 mg) were added to the lysate. After a 1 hr incubation,
the lysate was incubated for another 1 hr with glutathione-Sepharose 4B
beads (GE Healthcare). The beads were subsequently washed in HS buffer.
Preparation of Recombinant Nezha-CC1F-His and Capping
Experiments
Fusion proteins were purified by using a His-Trap column (GE Healthcare) and
subjected to labeling with Alexa Fluor-488 Protein Labeling kit (Invitrogen). The
in vitro microtubule-capping experiment was performed as described previ-
ously (Wiese and Zheng, 2000). Briefly, we mixed 4 ml of 2 mg/ml rhoda-
mine-labeled tubulin (Cytoskeleton) and 1 ml of 2 nM Alexa 488-labeled
Nezha-CC1F-His, both of which contained 10 mM Taxol. This mixture was in-
cubated for 5 min at 37C, and then 3 volumes of nonlabeled tubulin, prepared
from rat brains as described earlier (Maekawa et al., 2001), were added. After
another 15 min incubation at 37C, the reaction was stopped by adding 10 vol-
umes of 1% glutaraldehyde at 23C and incubating the mixture for 3 min, and
then the solution was diluted with 250 ml of 80% glycerol in BRB80. Each re-
action mixture was spotted onto a microscope slide, covered with a coverslip,
and viewed under an epifluorescence microscope through a Plan Apochromat
633/1.4 lens (Carl Zeiss).
Live-Cell Imaging, Image Processing, and Statistical Analysis
Live-cell imaging was performed by using a Delta Vision microscope (Applied
Precision), and the digital images thus obtained were analyzed as described
previously (Kametani and Takeichi, 2007). Time-lapse image series were ac-
quired at 2 s or 5 s intervals at 37C. Fluorescence intensity and cell-surface
areas were measured by using Image J. All statistical analysis was performed
by using Student’s t test with Excel (Microsoft). Error bars in the figures
represent ± SD.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, 11 fig-
ures, and three movies and can be found with this article online at http://
www.cell.com/supplemental/S0092-8674(08)01197-5.
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